本页面由Tiger Trade Technology Pte. Ltd.提供服务

Vera Therapeutics, Inc.

32.29
-1.0900-3.27%
盘后32.500.2100+0.65%17:57 EDT
成交量:151.57万
成交额:4,883.10万
市值:23.16亿
市盈率:-5.79
高:34.06
开:33.38
低:31.40
收:33.38
52周最高:56.05
52周最低:19.07
股本:7,171.39万
流通股本:5,019.82万
量比:0.99
换手率:3.02%
股息:- -
股息率:- -
每股收益(TTM):-5.5746
每股收益(LYR):-4.6644
净资产收益率:-71.32%
总资产收益率:-38.90%
市净率:4.63
市盈率(LYR):-6.92

数据加载中...

2026/06/02

重要事件披露

Form 8-K - Current report
2026/05/27

重要事件披露

Form 8-K - Current report
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/07

重要事件披露

Form 8-K - Current report
2026/04/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/01

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/03/09

重要事件披露

Form 8-K - Current report
2026/02/27

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/02/26

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/26

重要事件披露

Form 8-K - Current report
2026/02/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/18

重要事件披露

Form 8-K - Current report
2025/12/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities